Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
暂无分享,去创建一个
[1] Yong Zhou,et al. Roll: a new algorithm for the detection of protein pockets and cavities with a rolling probe sphere , 2010, Bioinform..
[2] M. Schroeder,et al. LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation , 2006, BMC Structural Biology.
[3] Ajay N. Jain,et al. Automatic identification and representation of protein binding sites for molecular docking , 1997, Protein science : a publication of the Protein Society.
[4] John Kuriyan,et al. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). , 2001, Cancer research.
[5] E. Istvan,et al. Statin inhibition of HMG-CoA reductase: a 3-dimensional view. , 2003, Atherosclerosis. Supplements.
[6] R. Abagyan,et al. Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.
[7] X. Barril,et al. Understanding and predicting druggability. A high-throughput method for detection of drug binding sites. , 2010, Journal of medicinal chemistry.
[8] D. Levitt,et al. POCKET: a computer graphics method for identifying and displaying protein cavities and their surrounding amino acids. , 1992, Journal of molecular graphics.
[9] P. Hajduk,et al. Druggability indices for protein targets derived from NMR-based screening data. , 2005, Journal of medicinal chemistry.
[10] Hongbo Zhu,et al. MSPocket: an orientation-independent algorithm for the detection of ligand binding pockets , 2011, Bioinform..
[11] C. Venkatachalam,et al. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. , 2003, Journal of molecular graphics & modelling.
[12] Alexander D. MacKerell,et al. Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces , 2007, J. Chem. Inf. Model..
[13] Scott P. Brown,et al. Effects of Conformational Dynamics on Predicted Protein Druggability , 2006, ChemMedChem.
[14] Frank K. Pettit,et al. HotPatch: a statistical approach to finding biologically relevant features on protein surfaces. , 2007, Journal of molecular biology.
[15] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[16] Thomas A. Halgren,et al. Identifying and Characterizing Binding Sites and Assessing Druggability , 2009, J. Chem. Inf. Model..
[17] P E Bourne,et al. The Protein Data Bank. , 2002, Nucleic acids research.
[18] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[19] J. Delaney. Finding and filling protein cavities using cellular logic operations. , 1992, Journal of molecular graphics.
[20] Nagasuma Chandra,et al. PocketDepth: a new depth based algorithm for identification of ligand binding sites in proteins. , 2008, Journal of structural biology.
[21] B. Honig,et al. On the nature of cavities on protein surfaces: Application to the identification of drug‐binding sites , 2006, Proteins.
[22] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..
[23] Haruki Nakamura,et al. Prediction of ligand‐binding sites of proteins by molecular docking calculation for a random ligand library , 2011, Protein science : a publication of the Protein Society.
[24] M Hendlich,et al. LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins. , 1997, Journal of molecular graphics & modelling.
[25] D. Ringe,et al. Locating and characterizing binding sites on proteins , 1996, Nature Biotechnology.
[26] F. J. Luque,et al. Binding site detection and druggability index from first principles. , 2009, Journal of medicinal chemistry.
[27] D. Goodsell,et al. Automated prediction of ligand‐binding sites in proteins , 2007, Proteins.
[28] S. J. Campbell,et al. Visualizing the drug target landscape. , 2010, Drug discovery today.
[29] Sandor Vajda,et al. Identification of hot spots within druggable binding regions by computational solvent mapping of proteins. , 2007, Journal of medicinal chemistry.
[30] Richard M. Jackson,et al. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites , 2005, Bioinform..
[31] R. Abagyan,et al. Comprehensive identification of "druggable" protein ligand binding sites. , 2004, Genome informatics. International Conference on Genome Informatics.
[32] Daniel R. Caffrey,et al. Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.
[33] Philip E. Bourne,et al. A robust and efficient algorithm for the shape description of protein structures and its application in predicting ligand binding sites , 2007, BMC Bioinformatics.
[34] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[35] R. Laskowski. SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions. , 1995, Journal of molecular graphics.
[36] G. Schneider,et al. PocketPicker: analysis of ligand binding-sites with shape descriptors , 2007, Chemistry Central Journal.
[37] C. Frömmel,et al. The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. , 1996, Journal of molecular biology.
[38] Robert P. Sheridan,et al. Drug-like Density: A Method of Quantifying the "Bindability" of a Protein Target Based on a Very Large Set of Pockets and Drug-like Ligands from the Protein Data Bank , 2010, J. Chem. Inf. Model..
[39] Sandor Vajda,et al. Computational mapping identifies the binding sites of organic solvents on proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] H. Edelsbrunner,et al. Anatomy of protein pockets and cavities: Measurement of binding site geometry and implications for ligand design , 1998, Protein science : a publication of the Protein Society.
[41] M. Jacobson,et al. Binding-Site Assessment by Virtual Fragment Screening , 2010, PloS one.
[42] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[43] John P. Overington,et al. Genomic-scale prioritization of drug targets: the TDR Targets database , 2008, Nature Reviews Drug Discovery.
[44] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[45] David S. Wishart,et al. HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..
[46] G. Kellogg,et al. A novel and efficient tool for locating and characterizing protein cavities and binding sites , 2010, Proteins.
[47] Chris M. W. Ho,et al. Cavity search: An algorithm for the isolation and display of cavity-like binding regions , 1990, J. Comput. Aided Mol. Des..
[48] Matthias Rarey,et al. Analyzing the Topology of Active Sites: On the Prediction of Pockets and Subpockets , 2010, J. Chem. Inf. Model..
[49] Ryan G. Coleman,et al. Protein Pockets: Inventory, Shape, and Comparison , 2010, J. Chem. Inf. Model..
[50] Vincent Le Guilloux,et al. Fpocket: An open source platform for ligand pocket detection , 2009, BMC Bioinformatics.
[51] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[52] G J Kleywegt,et al. Detection, delineation, measurement and display of cavities in macromolecular structures. , 1994, Acta crystallographica. Section D, Biological crystallography.